Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2019 | Key updates on testicular cancer management

Robert Huddart • 15 Feb 2019
GU Cancers 2019
Genitourinary Cancer Testicular Cancer

Robert Huddart, MBBS, MRCP, FRCR, PhD, of The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK, reviews important updates on testicular cancer management, including the value of micro-RNA as biomarkers in testicular cancer prognosis, and the use of adjuvant chemotherapy for treating non-seminomatous testicular tumors. This video was recorded at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.

More from Robert Huddart

4:26
Adaptive image guided radiotherapy for muscle invasive bladder cancer
Robert Huddart • 16 Feb 2023
4:11
TRISST: cost-effectiveness of alternative imaging and surveillance schedules for testicular seminoma
Robert Huddart • 16 Feb 2023
2:00
Late recurrences of nonseminomatous germ cell malignancies
Robert Huddart • 15 Feb 2019
4:10
Combination of minimally invasive surgery and carboplatin for stage IIa seminoma
Robert Huddart • 15 Feb 2019

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals